Dose and BTK occupancy relationship in the prospective Phase 2 TAILOR study: Exploratory end point analysis of the ibrutinib monotherapy cohorts in patients with previously untreated chronic lymphocytic leukemia
Jacqueline C. Barrientos, Michael Doubek, Zsolt I. Lázár, Andrea Visentin et autres